ARS Pharmaceuticals Inc (NASDAQ:SPRY) traded at $9.16 at close of the session on Friday, March 15, made an upward move of 1.78% on its previous day’s price.
Looking at the stock we see that its previous close was $9.00 . In terms of its 52-week price range, SPRY has a high of $9.65 and a low of $2.55. The company’s stock has gained about 29.01% over that past 30 days.
ARS Pharmaceuticals Inc has a market cap of $879.36 million and is expected to release its quarterly earnings report on Mar 21, 2024 – Mar 25, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.14, with the EPS growth for the year raised at -$0.64 for 2023 and -$0.75 for next year. These figures represent 26.40% and -17.20% growth in EPS for the two years respectively.
According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2023 is expected to hit $10k, or -99.20% down from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the SPRY stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 50% Buy.
Looking further, we note the current price level is 9.13% off its SMA20 and 28.36% from its 50-day simple moving average. The RSI (14) is pointing at 67.10 while the volatility over the past week is 4.75% and jumps to 6.34% over the past one month. The beta value is 0.77, while the average true range (ATR) is currently pointing at 0.46.
Coming back to ARS Pharmaceuticals Inc (NASDAQ:SPRY), we note that the average 3-month trading volume was 474.42K, while that of the preceding 10-day period stands at 0.75 million. Current shares outstanding are 93.94 million.
The insiders hold 56.92% of the company’s shares while institutions hold 40.87%. The data shows that short shares as of Feb 29, 2024, stood at 4.61 million at a short ratio of 7.64. This represents a 4.80% short interest in shares outstanding on Feb 29, 2024. Shares short fall in February from the previous month at 4.86 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 67.15% up in year-to-date price movement.
